Third Harmonic Bio Liquidation Approved: $5.35 Per Share Distribution Coming Q3 2025

Stockholders overwhelmingly approved liquidation and dissolution of the Company

at the June 5, 2025 Annual Meeting

Initial distribution currently expected in the range between approximately $5.30 and $5.35 per share of common stock, expected in the third quarter of 2025

THB335 demonstrated 85% serum tryptase reduction with an encouraging safety profile in an additional Phase 1 cohort evaluating 100mg dose with new drug product capsule formulation

Company initiating a sale process of THB335

SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) — Third Harmonic Bio, Inc. (Nasdaq: THRD) today announced that its stockholders overwhelmingly approved the previously proposed Plan of Liquidation and Dissolution (the “Plan of…